title: Will comparative effectiveness research finally succeed?
abstract: Autonomy, innovation, and drug access may be at stake along with personalized medicine. Can all stakeholders be satisfied and should cost be a factor?
authors.forename: Erwin A
authors.initials: EA
authors.lastname: Blackstone
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Fuhr
authors.forename: Danielle
authors.initials: D
authors.lastname: Ziernicki